12月9日，藍(lan)豐(feng)生化發布公(gong)(gong)(gong)(gong)告稱，公(gong)(gong)(gong)(gong)司(si)(si)控(kong)股子公(gong)(gong)(gong)(gong)司(si)(si)安(an)(an)徽旭(xu)合新(xin)能源科技(ji)有(you)限公(gong)(gong)(gong)(gong)司(si)(si)（以下(xia)簡稱“旭(xu)合科技(ji)”）經營發展需要，擬引(yin)入投資(zi)(zi)者長安(an)(an)國際信托(tuo)股份有(you)限公(gong)(gong)(gong)(gong)司(si)(si)（代表(biao)(biao)“長安(an)(an)信托(tuo)·新(xin)禾(he)1號財富(fu)管(guan)理服務”，以下(xia)簡稱“長安(an)(an)信托(tuo)”）對其進行增(zeng)資(zi)(zi)，增(zeng)資(zi)(zi)金額為(wei)(wei)人民幣9,801萬(wan)元，其中1,782萬(wan)計(ji)入注冊資(zi)(zi)本，8,019萬(wan)元計(ji)入資(zi)(zi)本公(gong)(gong)(gong)(gong)積。本次(ci)增(zeng)資(zi)(zi)完成后，公(gong)(gong)(gong)(gong)司(si)(si)持有(you)旭(xu)合科技(ji)的股權比例將由增(zeng)資(zi)(zi)前的51%變更為(wei)(wei)49.2449%，旭(xu)合科技(ji)仍為(wei)(wei)公(gong)(gong)(gong)(gong)司(si)(si)控(kong)股子公(gong)(gong)(gong)(gong)司(si)(si)，不涉及合并報表(biao)(biao)范圍(wei)的變更。

近日(ri)，旭合科技就上(shang)述交易事項已辦(ban)理完成相關工商(shang)變更(geng)登記手(shou)續，并取得了由中新蘇滁高(gao)新技術產業開發區市場監督管(guan)理局(ju)換(huan)發的《營業執照》。

公(gong)告指出，為把(ba)握當前光(guang)伏行業高速發(fa)(fa)展的(de)(de)行業機遇，加強公(gong)司(si)光(guang)伏業務的(de)(de)戰(zhan)略布(bu)局，進一(yi)步提高公(gong)司(si)整體(ti)(ti)資(zi)本實力和綜(zong)合(he)(he)競爭力，公(gong)司(si)作(zuo)為旭合(he)(he)科技原(yuan)股(gu)東放棄本次 增資(zi)優先(xian)認繳權，是考慮公(gong)司(si)整體(ti)(ti)戰(zhan)略規(gui)劃作(zuo)出的(de)(de)謹(jin)慎(shen)決策(ce)，符合(he)(he)公(gong)司(si)未(wei)來整體(ti)(ti)發(fa)(fa)展規(gui)劃和長遠利(li)(li)益，同時本次增資(zi)有利(li)(li)于改(gai)善旭合(he)(he)科技的(de)(de)資(zi)產(chan)負債結構，降低 其資(zi)產(chan)負債率。